标题
New developments in pharmacotherapy for Friedreich ataxia
作者
关键词
-
出版物
EXPERT OPINION ON PHARMACOTHERAPY
Volume -, Issue -, Pages 1-13
出版商
Informa UK Limited
发表日期
2019-07-17
DOI
10.1080/14656566.2019.1639671
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Randomized, double-blind, placebo-controlled study of interferon-γ 1b in Friedreich Ataxia
- (2019) David R. Lynch et al. Annals of Clinical and Translational Neurology
- Risks and benefits of corticosteroids in arthritic diseases in the clinic
- (2019) Ioanna Petta et al. BIOCHEMICAL PHARMACOLOGY
- Hypoxia Rescues Frataxin Loss by Restoring Iron Sulfur Cluster Biogenesis
- (2019) Tslil Ast et al. CELL
- Liquid Chromatography-High Resolution Mass Spectrometry Analysis of Platelet Frataxin as a Protein Biomarker for the Rare Disease Friedreich’s Ataxia
- (2018) Lili Guo et al. ANALYTICAL CHEMISTRY
- Peripheral blood gene expression reveals an inflammatory transcriptomic signature in Friedreich’s ataxia patients
- (2018) Daniel Nachun et al. HUMAN MOLECULAR GENETICS
- Impact of Drosophila Models in the Study and Treatment of Friedreich’s Ataxia
- (2018) Véronique Monnier et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Randomized, clinical trial of RT001: Early signals of efficacy in Friedreich's ataxia
- (2018) Theresa Zesiewicz et al. MOVEMENT DISORDERS
- Low apolipoprotein A-I levels in Friedreich’s ataxia and in frataxin-deficient cells: Implications for therapy
- (2018) QingQing Wang et al. PLoS One
- Drosophila melanogaster Models of Friedreich’s Ataxia
- (2018) P. Calap-Quintana et al. Biomed Research International
- Mechanisms of toxic cardiomyopathy
- (2018) Philippe Hantson CLINICAL TOXICOLOGY
- Transcriptional profiling of isogenic Friedreich ataxia neurons and effect of an HDAC inhibitor on disease signatures
- (2018) Jiun-I Lai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Characterization of a new N-terminally acetylated extra-mitochondrial isoform of frataxin in human erythrocytes
- (2018) Lili Guo et al. Scientific Reports
- Safety, pharmacodynamics, and potential benefit of omaveloxolone in Friedreich ataxia
- (2018) David R. Lynch et al. Annals of Clinical and Translational Neurology
- Pharmacological therapeutics in Friedreich ataxia: the present state
- (2017) Cassandra Strawser et al. Expert Review of Neurotherapeutics
- Nrf2-Inducers Counteract Neurodegeneration in Frataxin-Silenced Motor Neurons: Disclosing New Therapeutic Targets for Friedreich’s Ataxia
- (2017) Sara Petrillo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Advances in the Treatment of Duchenne Muscular Dystrophy: New and Emerging Pharmacotherapies
- (2017) Andrea M. Reinig et al. PHARMACOTHERAPY
- A Critical Assessment of the Therapeutic Potential of Resveratrol Supplements for Treating Mitochondrial Disorders
- (2017) Boel De Paepe et al. Nutrients
- Inducible and reversible phenotypes in a novel mouse model of Friedreich’s Ataxia
- (2017) Vijayendran Chandran et al. eLife
- Pharmacological therapeutics in Friedreich ataxia: the present state
- (2017) Cassandra Strawser et al. Expert Review of Neurotherapeutics
- Impact of diabetes in the Friedreich ataxia clinical outcome measures study
- (2017) Ashley McCormick et al. Annals of Clinical and Translational Neurology
- Selected missense mutations impair frataxin processing in Friedreich ataxia
- (2017) Elisia Clark et al. Annals of Clinical and Translational Neurology
- Abundance and Significance of Iron, Zinc, Copper, and Calcium in the Hearts of Patients With Friedreich Ataxia
- (2016) Pamela C. Kruger et al. AMERICAN JOURNAL OF CARDIOLOGY
- Compound heterozygousFXNmutations and clinical outcome in friedreich ataxia
- (2016) Charles A. Galea et al. ANNALS OF NEUROLOGY
- Establishment and Maintenance of Primary Fibroblast Repositories for Rare Diseases—Friedreich's Ataxia Example
- (2016) Yanjie Li et al. BIOPRESERVATION AND BIOBANKING
- Friedreich Ataxia and nephrotic syndrome: a series of two patients
- (2016) Julianna E. Shinnick et al. BMC Neurology
- Using human pluripotent stem cells to study Friedreich ataxia cardiomyopathy
- (2016) Duncan E. Crombie et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Progression characteristics of the European Friedreich’s Ataxia Consortium for Translational Studies (EFACTS): a 2 year cohort study
- (2016) Kathrin Reetz et al. LANCET NEUROLOGY
- Effects of genetic severity on glucose homeostasis in Friedreich ataxia
- (2016) Charles J. Isaacs et al. MUSCLE & NERVE
- Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy
- (2016) David Gloss et al. NEUROLOGY
- Reversal of epigenetic promoter silencing in Friedreich ataxia by a class I histone deacetylase inhibitor
- (2016) Yogesh K. Chutake et al. NUCLEIC ACIDS RESEARCH
- Metal Homeostasis Regulators Suppress FRDA Phenotypes in a Drosophila Model of the Disease
- (2016) Sirena Soriano et al. PLoS One
- The Rise and Fall of the d -Serine-Mediated Gliotransmission Hypothesis
- (2016) Herman Wolosker et al. TRENDS IN NEUROSCIENCES
- Establishment and Maintenance of Primary Fibroblast Repositories for Rare Diseases—Friedreich's Ataxia Example
- (2016) Yanjie Li et al. Biopreservation and Biobanking
- Loss of Frataxin activates the iron/sphingolipid/PDK1/Mef2 pathway in mammals
- (2016) Kuchuan Chen et al. eLife
- Translating HDAC inhibitors in Friedreich’s ataxia
- (2016) Elisabetta Soragni et al. Expert Opinion on Orphan Drugs
- Progression of Friedreich ataxia: quantitative characterization over 5 years
- (2016) Maya Patel et al. Annals of Clinical and Translational Neurology
- Dorsal root ganglia in Friedreich ataxia: satellite cell proliferation and inflammation
- (2016) Arnulf H. Koeppen et al. Acta Neuropathologica Communications
- Mitoferrin modulates iron toxicity in a Drosophila model of Friedreich׳s ataxia
- (2015) Juan A. Navarro et al. FREE RADICAL BIOLOGY AND MEDICINE
- An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levels
- (2015) Eppie M. Yiu et al. JOURNAL OF NEUROLOGY
- Biological and clinical characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) cohort: a cross-sectional analysis of baseline data
- (2015) Kathrin Reetz et al. LANCET NEUROLOGY
- Molecular Mechanisms and Therapeutic Effects of (−)-Epicatechin and Other Polyphenols in Cancer, Inflammation, Diabetes, and Neurodegeneration
- (2015) Joseph Shay et al. Oxidative Medicine and Cellular Longevity
- Stable isotopes and LC–MS for monitoring metabolic disturbances in Friedreich's ataxia platelets
- (2015) Andrew J Worth et al. Bioanalysis
- RTA 408, A Novel Synthetic Triterpenoid with Broad Anticancer and Anti-Inflammatory Activity
- (2015) Brandon L. Probst et al. PLoS One
- FXN Promoter Silencing in the Humanized Mouse Model of Friedreich Ataxia
- (2015) Yogesh K. Chutake et al. PLoS One
- Open-label pilot study of interferon gamma-1b in Friedreich ataxia
- (2014) L. Seyer et al. ACTA NEUROLOGICA SCANDINAVICA
- Epigenetic promoter silencing in Friedreich ataxia is dependent on repeat length
- (2014) Yogesh K. Chutake et al. ANNALS OF NEUROLOGY
- Deferiprone in Friedreich ataxia: A 6-Month randomized controlled trial
- (2014) Massimo Pandolfo et al. ANNALS OF NEUROLOGY
- Dyclonine rescues frataxin deficiency in animal models and buccal cells of patients with Friedreich's ataxia
- (2014) Sunil Sahdeo et al. HUMAN MOLECULAR GENETICS
- Altered Nucleosome Positioning at the Transcription Start Site and Deficient Transcriptional Initiation in Friedreich Ataxia
- (2014) Yogesh K. Chutake et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cross-sectional analysis of glucose metabolism in Friedreich Ataxia
- (2014) Nathaniel R. Greeley et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Epigenetic and neurological effects and safety of high-dose nicotinamide in patients with Friedreich's ataxia: an exploratory, open-label, dose-escalation study
- (2014) Vincenzo Libri et al. LANCET
- Triple therapy with deferiprone, idebenone and riboflavin in Friedreich's ataxia - open-label trial
- (2013) J. Arpa et al. ACTA NEUROLOGICA SCANDINAVICA
- Frataxin Deficiency Leads to Defects in Expression of Antioxidants and Nrf2 Expression in Dorsal Root Ganglia of the Friedreich's Ataxia YG8R Mouse Model
- (2013) Yuxi Shan et al. ANTIOXIDANTS & REDOX SIGNALING
- Heterochromatinization induced by GAA-repeat hyperexpansion in Friedreich's ataxia can be reduced upon HDAC inhibition by vitamin B3
- (2013) P. K. Chan et al. HUMAN MOLECULAR GENETICS
- Co-enzyme Q10and idebenone use in Friedreich's ataxia
- (2013) Michael H Parkinson et al. JOURNAL OF NEUROCHEMISTRY
- Erythropoietin in Friedreich ataxia
- (2013) Caterina Mariotti et al. JOURNAL OF NEUROCHEMISTRY
- Increasing frataxin gene expression with histone deacetylase inhibitors as a therapeutic approach for Friedreich's ataxia
- (2013) Joel M. Gottesfeld et al. JOURNAL OF NEUROCHEMISTRY
- Deferiprone for the treatment of Friedreich's ataxia
- (2013) Massimo Pandolfo et al. JOURNAL OF NEUROCHEMISTRY
- Clinical features of Friedreich's ataxia: classical and atypical phenotypes
- (2013) Michael H. Parkinson et al. JOURNAL OF NEUROCHEMISTRY
- Animal and cellular models of Friedreich ataxia
- (2013) Morgane Perdomini et al. JOURNAL OF NEUROCHEMISTRY
- Modeling of Friedreich ataxia-related iron overloading cardiomyopathy using patient-specific-induced pluripotent stem cells
- (2013) Yee-Ki Lee et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Development of Frataxin Gene Expression Measures for the Evaluation of Experimental Treatments in Friedreich’s Ataxia
- (2013) Heather L. Plasterer et al. PLoS One
- Human platelets as a platform to monitor metabolic biomarkers using stable isotopes and LC–MS
- (2013) Sankha S Basu et al. Bioanalysis
- Insights into the role of oxidative stress in the pathology of Friedreich ataxia using peroxidation resistant polyunsaturated fatty acids
- (2013) M. Grazia Cotticelli et al. Redox Biology
- Central role and mechanisms of β-cell dysfunction and death in friedreich ataxia-associated diabetes
- (2012) Miriam Cnop et al. ANNALS OF NEUROLOGY
- Neurons and cardiomyocytes derived from induced pluripotent stem cells as a model for mitochondrial defects in Friedreich's ataxia
- (2012) A. Hick et al. Disease Models & Mechanisms
- Understanding the genetic and molecular pathogenesis of Friedreich's ataxia through animal and cellular models
- (2012) A. Martelli et al. Disease Models & Mechanisms
- Interferon gamma upregulates frataxin and corrects the functional deficits in a Friedreich ataxia model
- (2012) B. Tomassini et al. HUMAN MOLECULAR GENETICS
- d-Serine: A key to synaptic plasticity?
- (2012) Christian Henneberger et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Friedreich Ataxia Clinical Outcome Measures
- (2012) Sean R. Regner et al. JOURNAL OF CHILD NEUROLOGY
- Therapeutic Developments in Friedreich Ataxia
- (2012) Robert B. Wilson JOURNAL OF CHILD NEUROLOGY
- Rationale for the Development of 2-Aminobenzamide Histone Deacetylase Inhibitors as Therapeutics for Friedreich Ataxia
- (2012) Elisabetta Soragni et al. JOURNAL OF CHILD NEUROLOGY
- A0001 in Friedreich ataxia: Biochemical characterization and effects in a clinical trial
- (2012) David R. Lynch et al. MOVEMENT DISORDERS
- Idebenone in Friedreich ataxia cardiomyopathy—results from a 6-month phase III study (IONIA)
- (2011) Sarah J. Lagedrost et al. AMERICAN HEART JOURNAL
- A gene expression phenotype in lymphocytes from friedreich ataxia patients
- (2011) Giovanni Coppola et al. ANNALS OF NEUROLOGY
- FXN methylation predicts expression and clinical outcome in Friedreich ataxia
- (2011) Marguerite V. Evans-Galea et al. ANNALS OF NEUROLOGY
- Effects of Erythropoietin on Frataxin Levels and Mitochondrial Function in Friedreich Ataxia – a Dose–Response Trial
- (2011) Wolfgang Nachbauer et al. CEREBELLUM
- Assessment of neurological efficacy of idebenone in pediatric patients with Friedreich's ataxia: data from a 6-month controlled study followed by a 12-month open-label extension study
- (2011) Thomas Meier et al. JOURNAL OF NEUROLOGY
- Mortality in Friedreich Ataxia
- (2011) Amy Y. Tsou et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Initial experience in the treatment of inherited mitochondrial disease with EPI-743
- (2011) Gregory M. Enns et al. MOLECULAR GENETICS AND METABOLISM
- Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
- (2011) Gina M. DeNicola et al. NATURE
- Prolonged treatment with pimelic o-aminobenzamide HDAC inhibitors ameliorates the disease phenotype of a Friedreich ataxia mouse model
- (2011) Chiranjeevi Sandi et al. NEUROBIOLOGY OF DISEASE
- Differential Expression of PGC-1α and Metabolic Sensors Suggest Age-Dependent Induction of Mitochondrial Biogenesis in Friedreich Ataxia Fibroblasts
- (2011) José Luis García-Giménez et al. PLoS One
- Isotopic reinforcement of essential polyunsaturated fatty acids diminishes nigrostriatal degeneration in a mouse model of Parkinson's disease
- (2011) Mikhail S. Shchepinov et al. TOXICOLOGY LETTERS
- A Phase 3, Double-blind, Placebo-Controlled Trial of Idebenone in Friedreich Ataxia
- (2010) David R. Lynch et al. ARCHIVES OF NEUROLOGY
- Combined Therapy with Idebenone and Deferiprone in Patients with Friedreich’s Ataxia
- (2010) Daniel Velasco-Sánchez et al. CEREBELLUM
- Measuring the rate of progression in Friedreich ataxia: Implications for clinical trial design
- (2010) Lisa S. Friedman et al. MOVEMENT DISORDERS
- PGC-1alpha Down-Regulation Affects the Antioxidant Response in Friedreich's Ataxia
- (2010) Daniele Marmolino et al. PLoS One
- Chemical Probes Identify a Role for Histone Deacetylase 3 in Friedreich's Ataxia Gene Silencing
- (2009) Chunping Xu et al. CHEMISTRY & BIOLOGY
- Functional genomic analysis of frataxin deficiency reveals tissue-specific alterations and identifies the PPARγ pathway as a therapeutic target in Friedreich’s ataxia
- (2009) Giovanni Coppola et al. HUMAN MOLECULAR GENETICS
- The ins and outs of mitochondrial iron-loading: the metabolic defect in Friedreich’s ataxia
- (2009) Des R. Richardson et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Low-dose idebenone treatment in Friedreich’s ataxia with and without cardiac hypertrophy
- (2009) C. Rinaldi et al. JOURNAL OF NEUROLOGY
- Friedreich's ataxia: Oxidative stress and cytoskeletal abnormalities
- (2009) Marco Sparaco et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Impaired Nuclear Nrf2 Translocation Undermines the Oxidative Stress Response in Friedreich Ataxia
- (2009) Vincent Paupe et al. PLoS One
- PPAR-γ Agonist Azelaoyl PAF Increases Frataxin Protein and mRNA Expression. New Implications for the Friedreich’s Ataxia Therapy
- (2008) Daniele Marmolino et al. CEREBELLUM
- Heme Oxygenase-1 Regulates Cardiac Mitochondrial Biogenesis via Nrf2-Mediated Transcriptional Control of Nuclear Respiratory Factor-1
- (2008) Claude A. Piantadosi et al. CIRCULATION RESEARCH
- Idebenone in Friedreich's ataxia
- (2008) Caterina Tonon et al. EXPERT OPINION ON PHARMACOTHERAPY
- Urinary isoprostanes in Friedreich ataxia: Lack of correlation with disease features
- (2008) Lauren M. Myers et al. MOVEMENT DISORDERS
- Neurological effects of recombinant human erythropoietin in Friedreich's ataxia: A clinical pilot trial
- (2008) Sylvia Boesch et al. MOVEMENT DISORDERS
- Long intronic GAA•TTC repeats induce epigenetic changes and reporter gene silencing in a molecular model of Friedreich ataxia
- (2008) E. Soragni et al. NUCLEIC ACIDS RESEARCH
- HDAC Inhibitors Correct Frataxin Deficiency in a Friedreich Ataxia Mouse Model
- (2008) Myriam Rai et al. PLoS One
- Antioxidant use in Friedreich ataxia
- (2007) Lauren Myers et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started